Pilot Study of the Safety and Efficacy of Carvedilol in Pulmonary Arterial Hypertension
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether carvedilol treatment of patients with
pulmonary arterial hypertension and associated right heart failure is safe and results in an
improved function of the right heart.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Virginia Commonwealth University
Collaborators:
GlaxoSmithKline National Center for Research Resources (NCRR)